相关实验视频
Updated: Jan 15, 2026
06:59
Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
40.1K
早期动脉样硬化斑块发育的两相模型与LDL毒性影响
Abdush Salam Pramanik1, Bibaswan Dey1, G P Raja Sekhar2
1Department of Mathematics, University of North Bengal, Raja Rammohunpur, Darjeeling 734013, West Bengal, India.
Mathematical biosciences
|October 8, 2025
概括
一个新的模型表明,泡细胞中的胆固醇毒性如何减缓动脉样硬化斑块的生长. 增加的毒性加速细胞死亡,减少斑块大小并影响心血管疾病的进展.
科学领域:
- 生物医学工程 生物医学工程
- 心血管研究研究心血管研究
- 计算生物学 计算生物学
背景情况:
- 动脉样硬化是一种慢性炎症性疾病,其特征是动脉斑块的积累.
- 早期的斑块发育涉及巨细胞,泡细胞和炎症过程.
- 低密度脂蛋白 (LDL) 和其氧化形式 (oxLDL) 是形成斑块的关键因素.
研究的目的:
- 开发和分析早期动脉样硬化斑块的自由边界双相模型.
- 研究低密度脂蛋白 (LDL) 毒性对斑块发育的影响.
- 了解细胞因子和氧化LDL (oxLDL) 在单细胞招募和泡细胞形成中的作用.
主要方法:
- 开发了早期动脉样硬化斑块的自由边界双相计算模型.
- 单细胞化学吸引蛋白-1 (MCP-1) 的内置机制驱动了巨细胞的招募和oxLDL吸收.
- 模拟了细胞内胆固醇的积累及其随后的毒性导致泡细胞死亡.
主要成果:
- 该模型表明,斑块最初生长迅速,由于胆固醇诱导的毒性,生长速度下降.
- 控制毒性诱导细胞死亡的参数显著降低了斑块生长速度.
- 提高毒性值会增加炎症细胞体积分数,加速斑块的生长.
- 增加的细胞因子流促进了斑块的生长,而更高的oxLDL流抑制了它.
结论:
- 细胞内胆固醇毒性是调节早期动脉样硬化斑块发展的关键因素.
- 细胞因子和oxLDL流动力学在斑块生长中起着相反的作用.
- 该模型提供了对推动早期斑块进展的生物化学和细胞机制的洞察.
相关概念视频
01:30Atherosclerosis I: Introduction
916
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
916
01:38Inflammation
61.6K
Overview
61.6K
01:26Coronary Artery Disease II: Pathophysiology
367
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
367
01:30Coronary Artery Disease I: Introduction
878
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
878
01:26Atherosclerosis III: Management
319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
354
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
354